Cabrera Ranaldi, E.d.l.R.M.; Nuytemans, K.; Martinez, A.; Luca, C.C.; Keane, R.W.; de Rivero Vaccari, J.P.
Proof-of-Principle Study of Inflammasome Signaling Proteins as Diagnostic Biomarkers of the Inflammatory Response in Parkinson’s Disease. Pharmaceuticals 2023, 16, 883.
https://doi.org/10.3390/ph16060883
AMA Style
Cabrera Ranaldi EdlRM, Nuytemans K, Martinez A, Luca CC, Keane RW, de Rivero Vaccari JP.
Proof-of-Principle Study of Inflammasome Signaling Proteins as Diagnostic Biomarkers of the Inflammatory Response in Parkinson’s Disease. Pharmaceuticals. 2023; 16(6):883.
https://doi.org/10.3390/ph16060883
Chicago/Turabian Style
Cabrera Ranaldi, Erika d. l. R. M., Karen Nuytemans, Anisley Martinez, Corneliu C. Luca, Robert W. Keane, and Juan Pablo de Rivero Vaccari.
2023. "Proof-of-Principle Study of Inflammasome Signaling Proteins as Diagnostic Biomarkers of the Inflammatory Response in Parkinson’s Disease" Pharmaceuticals 16, no. 6: 883.
https://doi.org/10.3390/ph16060883
APA Style
Cabrera Ranaldi, E. d. l. R. M., Nuytemans, K., Martinez, A., Luca, C. C., Keane, R. W., & de Rivero Vaccari, J. P.
(2023). Proof-of-Principle Study of Inflammasome Signaling Proteins as Diagnostic Biomarkers of the Inflammatory Response in Parkinson’s Disease. Pharmaceuticals, 16(6), 883.
https://doi.org/10.3390/ph16060883